Table 5.
Results of hematological tests
| Intake Period (Weeks) | |||||
|---|---|---|---|---|---|
| Groups | n | 0 | 4 | 8 | |
| WBC (/μL) | 8 g | 29 | 5852 ± 258 | 5731 ± 198 | 5586 ± 264 |
| 6 g | 31 | 5877 ± 240 | 5755 ± 266 | 5926 ± 299 | |
| 4 g | 28 | 6336 ± 316 | 6004 ± 257 | 5979 ± 284 | |
| RBC (/μL) | 8 g | 29 | 498 ± 5 | 489 ± 6 | 495 ± 5 |
| 6 g | 31 | 494 ± 7 | 485 ± 6* | 488 ± 7 | |
| 4 g | 28 | 489 ± 5 | 489 ± 4 | 490 ± 5 | |
| Hb (g/dL) | 8 g | 29 | 15.1 ± 0.2 | 14.9 ± 0.2 | 15.0 ± 0.2 |
| 6 g | 31 | 15.0 ± 0.2 | 14.7 ± 0.2* | 14.8 ± 0.2 | |
| 4 g | 28 | 14.7 ± 0.1 | 14.8 ± 0.1 | 14.8 ± 0.1 | |
| Ht (%) | 8 g | 29 | 46.6 ± 0.5 | 45.7 ± 0.5 | 46.7 ± 0.5 |
| 6 g | 31 | 46.4 ± 0.5 | 45.3 ± 0.5* | 45.8 ± 0.6 | |
| 4 g | 28 | 45.8 ± 0.4 | 45.6 ± 0.4 | 45.9 ± 0.4 | |
| MCV (fl) | 8 g | 29 | 93.6 ± 0.6 | 93.5 ± 0.6 | 94.2 ± 0.6 |
| 6 g | 31 | 94.1 ± 0.6 | 93.5 ± 0.6 | 94.0 ± 0.6 | |
| 4 g | 28 | 93.6 ± 0.6 | 93.2 ± 0.6 | 93.7 ± 0.6 | |
| MCH (pg) | 8 g | 29 | 30.3 ± 0.2 | 30.4 ± 0.2 | 30.4 ± 0.2 |
| 6 g | 31 | 30.4 ± 0.2 | 30.3 ± 0.2 | 30.3 ± 0.2 | |
| 4 g | 28 | 30.1 ± 0.2 | 30.2 ± 0.2 | 30.2 ± 0.2 | |
| MCHC (%) | 8 g | 29 | 32.4 ± 0.1 | 32.6 ± 0.1 | 32.2 ± 0.1 |
| 6 g | 31 | 32.2 ± 0.1 | 32.4 ± 0.1 | 32.2 ± 0.1 | |
| 4 g | 28 | 32.2 ± 0.1 | 32.4 ± 0.1 | 32.3 ± 0.1 | |
| Platelet (/μL) | 8 g | 29 | 25.3 ± 0.8 | 25.0 ± 1.0 | 25.0 ± 0.9 |
| 6 g | 31 | 25.7 ± 1.3 | 24.8 ± 1.2 | 25.2 ± 1.2 | |
| 4 g | 28 | 24.5 ± 0.9 | 24.2 ± 0.9 | 24.4 ± 0.8 | |
Mean ± SE of 29 (8 g), 31 (6 g), and 28 (4 g), *: p < 0.05 vs. 0 weeks by Dunnett test